13G Filing: Rima Senvest Management and Syneron Medical Ltd. (ELOS)

Page 4 of 7 – SEC Filing

Item 1(a). Name of Issuer.
Syneron Medical Ltd. (the “Issuer“)
Item 1(b). Address of Issuer’s Principal Executive Offices.

Industrial Zone

Yokneam Illit

20692
P.O.B. 550

Israel

Item 2(a). Name of Person Filing.
This statement is filed by Senvest Management, LLC and Richard Mashaal.
The reported securities are held in the accounts of Senvest Master Fund, LP, Senvest Israel Partners Master Fund, LP and Senvest Global (KY), LP (collectively, the “Investment Vehicles“).
Senvest Management, LLC may be deemed to beneficially own the securities held by the Investment Vehicles by virtue of Senvest Management, LLC’s position as investment manager of the Investment Vehicles. Mr. Mashaal may be deemed to beneficially own the securities held by the Investment Vehicles by virtue of Mr. Mashaal’s status as the managing member of Senvest Management, LLC. None of the foregoing should be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of the Ordinary Shares reported herein.
Item 2(b). Address of Principal Business Office.

Senvest Management, LLC

540 Madison Avenue, 32nd Floor

New York, New York 10022

Richard Mashaal

c/o Senvest Management, LLC

540 Madison Avenue, 32nd Floor

New York, New York 10022

Item 2(c). Place of Organization.

Senvest Management, LLC – Delaware

Richard Mashaal – Canada

Item 2(d). Title of Class of Securities.
Ordinary Shares, par value NIS 0.01 per share
Item 2(e). CUSIP Number.
M87245102

Follow Syneron Medical Ltd. (NASDAQ:ELOS)